AngioVac system for infective endocarditis: A new treatment for an old disease

Ann Card Anaesth. 2023 Jan-Mar;26(1):105-108. doi: 10.4103/aca.aca_156_21.

Abstract

Three different patients presented to our institution with right-sided infective endocarditis (IE). All three were found to have vegetation on the tricuspid valve. These patients were started on appropriate antimicrobial therapy according to their blood cultures sensitivities. Despite this management, the patients' clinical status did not improve solely on antimicrobials. Surgery was, therefore, indicated to remove the vegetations. Traditionally, the appropriate management would have been invasive surgery. However, these patients were subjected to a novel treatment in our institution for right-sided IE: percutaneous mechanical vegetation debulking with an AngioVac system. After this procedure, all three patients' clinical status improved drastically. This new less invasive approach seems to offer the same results as the traditional invasive surgery, with faster recovery time. More comparative studies are needed to confirm this idea.

Keywords: AngioVac; IV drug use; endocarditis.

Publication types

  • Case Reports

MeSH terms

  • Endocarditis* / drug therapy
  • Endocarditis* / surgery
  • Endocarditis, Bacterial* / diagnostic imaging
  • Endocarditis, Bacterial* / drug therapy
  • Endocarditis, Bacterial* / surgery
  • Humans
  • Tricuspid Valve / diagnostic imaging
  • Tricuspid Valve / surgery